Postoperative chemoradiotherapy in high risk locally advanced gastric cancer |
Song, Sanghyuk
(Department of Radiation Oncology, Seoul National University College of Medicine)
Chie, Eui Kyu (Department of Radiation Oncology, Seoul National University College of Medicine) Kim, Kyubo (Department of Radiation Oncology, Seoul National University College of Medicine) Lee, Hyuk-Joon (Department of Surgery, Seoul National University College of Medicine) Yang, Han-Kwang (Department of Surgery, Seoul National University College of Medicine) Han, Sae-Won (Department of Internal Medicine, Seoul National University College of Medicine) Oh, Do-Youn (Department of Internal Medicine, Seoul National University College of Medicine) Im, Seock-Ah (Department of Internal Medicine, Seoul National University College of Medicine) Bang, Yung-Jue (Department of Internal Medicine, Seoul National University College of Medicine) Ha, Sung W. (Department of Radiation Oncology, Seoul National University College of Medicine) |
1 | Jung KW, Park S, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci 2010;25:1113-21. DOI ScienceOn |
2 | GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group, Paoletti X, Oba K, et al. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA 2010;303:1729-37. DOI ScienceOn |
3 | Bang YJ, Kim YW, Yang HK, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet 2012;379:315-21. DOI ScienceOn |
4 | Smalley SR, Benedetti JK, Haller DG, et al. Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol 2012;30:2327-33. DOI ScienceOn |
5 | Dikken JL, Jansen EP, Cats A, et al. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. J Clin Oncol 2010;28:2430-6. DOI ScienceOn |
6 | Lee J, Lim DH, Kim S, et al. Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. J Clin Oncol 2012;30:268-73. DOI ScienceOn |
7 | Kwon HC, Kim MC, Kim KH, et al. Adjuvant chemoradiation versus chemotherapy in completely resected advanced gastric cancer with D2 nodal dissection. Asia Pac J Clin Oncol 2010;6:278-85. DOI ScienceOn |
8 | Lim DH, Kim DY, Kang MK, et al. Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view. Br J Cancer 2004;91:11-7. DOI ScienceOn |
9 | Leong CN, Chung HT, Lee KM, et al. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma. Cancer J 2008;14:269-75. DOI ScienceOn |
10 | Tham CK, Choo SP, Poon DY, et al. Capecitabine with radiation is an effective adjuvant therapy in gastric cancers. World J Gastroenterol 2010;16:3709-15. DOI ScienceOn |
11 | Kim S, Kim JS, Jeong HY, Noh SM, Kim KW, Cho MJ. Retrospective analysis of treatment outcomes after postoperative chemoradiotherapy in advanced gastric cancer. Radiat Oncol J 2011;29:252-9. 과학기술학회마을 DOI ScienceOn |
12 | Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007;357:1810-20. DOI ScienceOn |
13 | Kulig J, Kolodziejczyk P, Sierzega M, et al. Adjuvant chemotherapy with etoposide, adriamycin and cisplatin compared with surgery alone in the treatment of gastric cancer: a phase III randomized, multicenter, clinical trial. Oncology 2010;78:54-61. DOI ScienceOn |
14 | Sun Z, Li DM, Wang ZN, et al. Prognostic significance of microscopic positive margins for gastric cancer patients with potentially curative resection. Ann Surg Oncol 2009;16:3028-37. DOI ScienceOn |